Off-label prescribing occurs when a medication is used for a purpose that is not approved by the Australian Therapeutic Goods Administration (TGA). It may involve

In recent weeks, the PDL Professional Officers have received a number of queries regarding pharmacists’ obligations and liability when dispensing Mounjaro® (tirzepatide). Tirzepatide is a

The PDL Professional Officers often manage calls, incident reports and occasional regulatory complaints following a pharmacist’s decision to decline supply of a medication. Recently, the

PDL is raising awareness with hospital pharmacists about the need to report incidents to PDL. This call has been prompted by a recent review of

Pharmacists are at the forefront of patient care, ensuring the safe and effective use of medications. Despite pharmacists best efforts, incidents can result in complaints,

PDL Professional Officers occasionally receive incident reports and notifications relating to breaches or concerns regarding access to a patient’s My Health Record. Some of these

PDL Professional Officers continue to receive enquiries and incident reports that have contributing factors such as pressure, stress, workload or fatigue. PDL recognises the high